ATCÄÚµå ¶Ç´Â ¼ººÐ¸í:  
°Ë»ö°á°ú: ÃÑ 6782°³ Áß 141 - 160
ATCÄڵ强ºÐ¸í
A02BX11TroxipideÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX12Bismuth subnitrateÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX13Alginic acidÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX14rebamipideÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX15teprenoneÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX16irsogladineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX51Carbenoxolone, combinations excl. psycholepticsÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX71Carbenoxolone, combinations with psycholepticsÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02BX77Gefarnate, combinations with psycholepticsÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A02XOTHER DRUGS FOR ACID RELATED DISORDERSÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERSÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03ADRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERSÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AASynthetic anticholinergics, esters with tertiary amino groupÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA01OxyphencyclimineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA03CamylofinÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA04MebeverineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA05TrimebutineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA06RociverineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA07DicycloverineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
A03AA08DihexyverineÁ¦Ç° °Ë»ö - WHOCC Á¶È¸
WHOCC Á¶È¸´Â? WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD À妽º¸¦ Á¶È¸ÇÕ´Ï´Ù.